跳至主要内容
临床试验/EUCTR2017-001260-37-NL
EUCTR2017-001260-37-NL进行中(未招募)1 期

PRODEO: PROfylactic Haloperidol in patients defined as high risk for DElirium with delirium risk mOdel - PRODEO

Zuyderland Medical Center0 个研究点开始时间: 2017年5月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age > 60 years
  • Planned elective surgery
  • High-risk of developing delirium according to the DEMO model
  • Absence of delirium pre-operatively
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 366
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1000

排除标准

  • Less than 1-day postoperative admission on ward
  • Hypersensitivity to butyrophenone-derivatives
  • Use of antipsychotics
  • Not being able to take oral medication
  • Presence of contraindications;
  • olesions of the basal ganglia,
  • oclinically significant heart disease,
  • oknown prolongation of the QT interval,
  • ohistory of ventricular arrhythmia and ‘torsades de pointes’,
  • ouncorrected hypokalemia.

研究者

发起方
Zuyderland Medical Center

相似试验

招募中
不适用
PRODEO: PROfylactic Haloperidol in patients defined as high risk for DElirium with delirium risk mOdelDelirium
NL-OMON45531Zuyderland Medisch Centrum1,366
招募中
3 期
Efficacy of haloperidol on symptom of opium withdrawal.
IRCT201702131457N12Mazandaran University of Medical Sciences74
已完成
4 期
Effects of prophylactic use of haloperidol in critically ill patients with a high risk for deliriumneuropsychiatric disorderacute confusiondelirium
NL-OMON39725niversitair Medisch Centrum Sint Radboud1,789
招募中
3 期
Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients: a prospective randomised multicenter double-blind placebo-controlled clinical trial
NL-OMON48650Erasmus MC, Universitair Medisch Centrum Rotterdam742
进行中(未招募)
1 期
Effectiveness of haloperidol for the treatment of acute confusional state (delirium) in patients treated at the intensive careDeliriumMedDRA version: 21.0Level: LLTClassification code 10012224Term: Delirium toxicSystem Organ Class: 100000004873MedDRA version: 21.1Level: LLTClassification code 10000702Term: Acute deliriumSystem Organ Class: 100000004873MedDRA version: 21.1Level: LLTClassification code 10042275Term: Subacute deliriumSystem Organ Class: 100000004873MedDRA version: 21.0Level: LLTClassification code 10012220Term: Delirium due to a general medical conditionSystem Organ Class: 100000004873MedDRA version: 21.0Level: LLTClassification code 10012226Term: Delirium, cause unknownSystem Organ Class: 100000004873MedDRA version: 21.0Level: LLTClassification code 10071313Term: Hypoactive deliriumSystem Organ Class: 100000004873MedDRA version: 21.0Level: LLTClassification code 10071314Term: Hyperactive deliriumSystem Organ Class: 100000004873MedDRA version: 21.0Level: LLTClassification code 10071315Term: Mixed deliriumSystem Organ Class: 100000004873
EUCTR2017-003115-20-NLErasmus Medical Center Rotterdam742